Systemic exposure of oxaliplatin and docetaxel in gastric cancer patients with peritonitis carcinomatosis treated with intraperitoneal hyperthermic chemotherapy
- 1 February 2021
- journal article
- research article
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 47 (2) , 486-489
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Intraperitoneal chemotherapy in advanced gastric cancer. Meta-analysis of randomized trialsEuropean Journal of Surgical Oncology, 2014
- Peritoneal carcinomatosis of gastric origin: A population‐based study on incidence, survival and risk factorsInternational Journal of Cancer, 2013
- A sensitive combined assay for the quantification of paclitaxel, docetaxel and ritonavir in human plasma using liquid chromatography coupled with tandem mass spectrometryJournal of Chromatography B, 2011
- Rationale for Heating Oxaliplatin for the Intraperitoneal Treatment of Peritoneal CarcinomatosisAnnals of Surgery, 2011
- Pharmacokinetics of heated intraperitoneal oxaliplatinCancer Chemotherapy and Pharmacology, 2007
- Sensitive inductively coupled plasma mass spectrometry assay for the determination of platinum originating from cisplatin, carboplatin, and oxaliplatin in human plasma ultrafiltrateJournal of Mass Spectrometry, 2006
- Heated intra-operative intraperitoneal oxaliplatin alone and in combination with intraperitoneal irinotecan: Pharmacologic studiesEuropean Journal of Surgical Oncology, 2006
- Intraperitoneal chemotherapy with taxanes for ovarian cancer with peritoneal disseminationEuropean Journal of Surgical Oncology, 2006
- Prospective Evaluation of the Pharmacokinetics and Toxicity Profile of Docetaxel in the ElderlyJournal of Clinical Oncology, 2005
- Invited Review: For the clinical application of thermochemotherapy given at mild temperaturesInternational Journal of Hyperthermia, 1999